{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:09Z","timestamp":1792036329759,"version":"4.4.0"},"reference-count":311,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.plipres.2023.101224","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T11:10:01Z","timestamp":1678273801000},"page":"101224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Sphingolipids and impaired hypoxic stress responses in Huntington disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Johannes","family":"Burtscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niran","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Riguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Di Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire P.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/1389450111007011237","article-title":"Hypothalamic and neuroendocrine changes in Huntington\u2019s disease","volume":"11","author":"Hult","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.plipres.2023.101224_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101358","article-title":"Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis","volume":"69","author":"Chuang","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","article-title":"Body weight and dietary factors in Huntington\u2019s disease patients compared with matched controls","volume":"1","author":"Sanberg","year":"1981","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0020","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1212\/WNL.0000000000012969","article-title":"Synaptic damage and its clinical correlates in people with early Huntington disease: a PET study","volume":"98","author":"Delva","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tips.2018.02.009","article-title":"The S1P axis: new exciting route for treating Huntington's Disease","volume":"39","author":"Di Pardo","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jnc.15044","article-title":"Role of sphingolipid metabolism in neurodegeneration","volume":"158","author":"Alaamery","year":"2021","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0050","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0055","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington\u2019s disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1016\/j.plipres.2023.101224_bb0060","first-page":"2621","article-title":"Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease","volume":"25","author":"Teo","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0065","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JHD-210495","article-title":"Abnormal spinal cord myelination due to oligodendrocyte dysfunction in a model of Huntington's disease","volume":"10","author":"Ferrari Bardile","year":"2021","journal-title":"J Huntington's Dis"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109308","article-title":"Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease","volume":"36","author":"Benraiss","year":"2021","journal-title":"Cell Rep"},{"issue":"19","key":"10.1016\/j.plipres.2023.101224_bb0080","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1073\/pnas.1818042116","article-title":"Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease","volume":"116","author":"Ferrari Bardile","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00401-021-02362-8","article-title":"Early white matter pathology in the fornix of the limbic system in Huntington disease","volume":"142","author":"Gabery","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.plipres.2023.101224_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/bs.irn.2018.09.006","article-title":"Structural magnetic resonance imaging in Huntington's disease","volume":"142","author":"Wilson","year":"2018","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"issue":"5334","key":"10.1016\/j.plipres.2023.101224_bb0100","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science (New York, NY)"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0105","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"19","key":"10.1016\/j.plipres.2023.101224_bb0125","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1073\/pnas.92.19.8710","article-title":"Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies","volume":"92","author":"Gutekunst","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0140","doi-asserted-by":"crossref","first-page":"eabj8812","DOI":"10.1126\/sciadv.abj8812","article-title":"Calcineurin and huntingtin form a calcium-sensing machinery that directs neurotrophic signals to the nucleus","volume":"8","author":"Scaramuzzino","year":"2022","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acsomega.7b01472","article-title":"Sphingomyelin and GM1 Influence Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes, ACS","volume":"3","author":"Chaibva","year":"2018","journal-title":"Omega"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13048","article-title":"The role of lipid metabolism in aging, lifespan regulation, and age-related disease","volume":"18","author":"Johnson","year":"2019","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0170","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18632\/aging.100630","article-title":"Serum profiling of healthy aging identifies phospho- and sphingolipid species as markers of human longevity","volume":"6","author":"Montoliu","year":"2014","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102118","article-title":"Regulation of the lysosome by sphingolipids: potential role in aging","volume":"298","author":"Tang","year":"2022","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"10.1016\/j.plipres.2023.101224_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0047-6374(00)00191-3","article-title":"Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging","volume":"120","author":"Lightle","year":"2000","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0190","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/aps.2009.136","article-title":"Increase in sphingolipid catabolic enzyme activity during aging","volume":"30","author":"Sacket","year":"2009","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-171054","article-title":"Age-dependent changes to sphingolipid balance in the human hippocampus are gender-specific and may sensitize to neurodegeneration","volume":"63","author":"Couttas","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0205","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.devcel.2021.03.032","article-title":"Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C","volume":"56","author":"Roney","year":"2021","journal-title":"Dev Cell"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/brain\/awz382","article-title":"Lipid metabolic pathways converge in motor neuron degenerative diseases","volume":"143","author":"Rickman","year":"2020","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/mds.28089","article-title":"Dysregulated brain cholesterol metabolism is linked to neuroinflammation in Huntington's disease","volume":"35","author":"Gonz\u00e1lez-Guevara","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","article-title":"Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies","volume":"28","author":"Goebel","year":"1978","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0240","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci"},{"issue":"17","key":"10.1016\/j.plipres.2023.101224_bb0245","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"10.1016\/j.plipres.2023.101224_bb0250","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166127","article-title":"Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease","volume":"1867","author":"Singh","year":"2021","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.plipres.2023.101224_bb0260","doi-asserted-by":"crossref","first-page":"31411","DOI":"10.1038\/srep31411","article-title":"Altered lipid metabolism in Drosophila model of Huntington's disease","volume":"6","author":"Aditi","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1388-1981(00)00054-8","article-title":"Sphingolipid transport in eukaryotic cells","volume":"1486","author":"van Meer","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"32","key":"10.1016\/j.plipres.2023.101224_bb0270","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0275","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbamem.2019.05.001","article-title":"Ceramide phosphoethanolamine, an enigmatic cellular membrane sphingolipid","volume":"1861","author":"Panevska","year":"2019","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"29","key":"10.1016\/j.plipres.2023.101224_bb0285","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.R200008200","article-title":"The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind","volume":"277","author":"Hannun","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2023.101224_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0005-2736(00)00210-8","article-title":"Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures","volume":"1469","author":"Sonnino","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.plipres.2023.101224_bb0305","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.plipres.2012.07.001","article-title":"Sphingolipids: critical players in Alzheimer\u2019s disease","volume":"51","author":"van Echten-Deckert","year":"2012","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2023.101224_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biochi.2013.07.027","article-title":"Ceramide and the mitochondrial respiratory chain","volume":"100","author":"Kogot-Levin","year":"2014","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb0320","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrm2977","article-title":"Revitalizing membrane rafts: new tools and insights","volume":"11","author":"Simons","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0325","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.embor.7400208","article-title":"The complex life of simple sphingolipids","volume":"5","author":"Futerman","year":"2004","journal-title":"EMBO Rep"},{"issue":"5867","key":"10.1016\/j.plipres.2023.101224_bb0330","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.plipres.2023.101224_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101162","article-title":"Sphingolipid control of cognitive functions in health and disease","volume":"86","author":"Kalinichenko","year":"2022","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","article-title":"Ceramide function in the brain: when a slight tilt is enough","volume":"70","author":"Mencarelli","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"6968","key":"10.1016\/j.plipres.2023.101224_bb0345","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature02188","article-title":"Molecular machinery for non-vesicular trafficking of ceramide","volume":"426","author":"Hanada","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.plipres.2023.101224_bb0350","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamem.2006.06.009","article-title":"Sphingolipid metabolism in neural cells","volume":"1758","author":"van Echten-Deckert","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0355","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic messengers: ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0360","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbalip.2013.08.006","article-title":"Sphingolipids and lifespan regulation","volume":"1841","author":"Huang","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2-3","key":"10.1016\/j.plipres.2023.101224_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1388-1981(00)00042-1","article-title":"Physiology and pathophysiology of sphingolipid metabolism and signaling","volume":"1485","author":"Huwiler","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"10.1016\/j.plipres.2023.101224_bb0370","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1002\/1873-3468.13114","article-title":"Emerging concepts of ganglioside metabolism","volume":"592","author":"Sandhoff","year":"2018","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0375","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0005-2736(86)90285-3","article-title":"Topology of glucosylceramide synthesis in Golgi membranes from porcine submaxillary glands","volume":"858","author":"Coste","year":"1986","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0380","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1074\/jbc.273.5.2939","article-title":"Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi","volume":"273","author":"Lannert","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2023.101224_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.653842","article-title":"Ganglioside GM1 targets astrocytes to stimulate cerebral energy metabolism","volume":"12","author":"Finsterwald","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0390","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","article-title":"Gangliosides are neuronal ligands for myelin-associated glycoprotein","volume":"93","author":"Yang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0395","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2023.101224_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.572965","article-title":"Gangliosides in the brain: physiology, pathophysiology and therapeutic applications","volume":"14","author":"Sipione","year":"2020","journal-title":"Front Neurosci"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0405","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"6446","key":"10.1016\/j.plipres.2023.101224_bb0410","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/365557a0","article-title":"Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens","volume":"365","author":"Olivera","year":"1993","journal-title":"Nature"},{"issue":"6585","key":"10.1016\/j.plipres.2023.101224_bb0415","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0425","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ncb2987","article-title":"Coupling between endocytosis and sphingosine kinase 1 recruitment","volume":"16","author":"Shen","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0430","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1096\/fj.201901734RR","article-title":"Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate","volume":"34","author":"Hait","year":"2020","journal-title":"FASEB J"},{"issue":"5945","key":"10.1016\/j.plipres.2023.101224_bb0435","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science (New York, NY)"},{"issue":"44","key":"10.1016\/j.plipres.2023.101224_bb0440","doi-asserted-by":"crossref","first-page":"37118","DOI":"10.1074\/jbc.M502207200","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"280","author":"Maceyka","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0445","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1096\/fj.10-167502","article-title":"Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration","volume":"25","author":"Strub","year":"2011","journal-title":"FASEB J"},{"issue":"40","key":"10.1016\/j.plipres.2023.101224_bb0450","doi-asserted-by":"crossref","first-page":"64886","DOI":"10.18632\/oncotarget.11714","article-title":"An oncogenic role for sphingosine kinase 2","volume":"7","author":"Neubauer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.plipres.2023.101224_bb0455","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0460","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.plipres.2023.101224_bb0465","first-page":"149","article-title":"Sphingosine-1 phosphate and central nervous system","volume":"378","author":"Martin","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0470","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1194\/jlr.R046300","article-title":"An update on the biology of sphingosine 1-phosphate receptors","volume":"55","author":"Blaho","year":"2014","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0475","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0480","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","article-title":"Roles for dysfunctional sphingolipid metabolism in Alzheimer\u2019s disease neuropathogenesis","volume":"1801","author":"Haughey","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081353","article-title":"Clinical sphingolipids pathway in parkinson's disease: from GCase to integrated-biomarker discovery","volume":"11","author":"Esfandiary","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0490","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0495","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"Chipuk","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0500","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0505","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1043-6618(03)00049-5","article-title":"The roles of ceramide and complex sphingolipids in neuronal cell function","volume":"47","author":"Buccoliero","year":"2003","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0510","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2018.03.042","article-title":"The brain lipidome in neurodegenerative lysosomal storage disorders","volume":"504","author":"Fuller","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0515","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.plipres.2011.11.004","article-title":"Lipid changes in the aged brain: effect on synaptic function and neuronal survival","volume":"51","author":"Ledesma","year":"2012","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2023.101224_bb0520","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fnins.2018.00249","article-title":"Sphingolipid metabolism: a new therapeutic opportunity for brain degenerative disorders","volume":"12","author":"Di Pardo","year":"2018","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0525","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The role of ceramide and sphingosine-1-phosphate in Alzheimer's disease and other neurodegenerative disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"7503","key":"10.1016\/j.plipres.2023.101224_bb0530","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0535","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0540","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12017-010-8114-x","article-title":"The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases","volume":"12","author":"Ben-David","year":"2010","journal-title":"NeuroMolecular Med"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0545","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00418-007-0344-0","article-title":"Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2\/Lass2","volume":"129","author":"Becker","year":"2008","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002063","article-title":"A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.plipres.2023.101224_bb0555","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fnins.2018.00464","article-title":"An overview of the role of lipofuscin in age-related neurodegeneration","volume":"12","author":"Moreno-Garc\u00eda","year":"2018","journal-title":"Front Neurosci"},{"issue":"12","key":"10.1016\/j.plipres.2023.101224_bb0560","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/j.1460-9568.2004.03852.x","article-title":"Elevation of the level and activity of acid ceramidase in Alzheimer\u2019s disease brain","volume":"20","author":"Huang","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0565","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1194\/jlr.R800007-JLR200","article-title":"Role of ganglioside metabolism in the pathogenesis of Alzheimer\u2019s disease--a review","volume":"49","author":"Ariga","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2023.101224_bb0570","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: treatment avenues in neurodegenerative disease","volume":"10","author":"Magistretti","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-021-02374-x","article-title":"Anti-inflammatory role of GM1 and other gangliosides on microglia","volume":"19","author":"Galleguillos","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0580","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","article-title":"Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years","volume":"63","author":"Svennerholm","year":"1994","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0585","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","article-title":"Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis","volume":"82","author":"Han","year":"2002","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0590","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","article-title":"Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer\u2019s disease","volume":"1801","author":"Han","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0595","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"4\u20135","key":"10.1016\/j.plipres.2023.101224_bb0600","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease?","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0605","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov Disord"},{"issue":"17","key":"10.1016\/j.plipres.2023.101224_bb0610","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLoS One"},{"issue":"9, Part B","key":"10.1016\/j.plipres.2023.101224_bb0620","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate \u2013 A double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0625","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0630","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0635","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2023.101224_bb0640","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo synthesis of sphingolipids is defective in experimental models of Huntington's disease","volume":"11","author":"Di Pardo","year":"2017","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0645","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymthe.2022.09.004","article-title":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington\u2019s disease","volume":"31","author":"Pepe","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.plipres.2023.101224_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105009","article-title":"Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease","volume":"143","author":"Di Pardo","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0655","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","article-title":"Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington\u2019s disease","volume":"115","author":"Denny","year":"2010","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0660","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0665","doi-asserted-by":"crossref","first-page":"fcab303","DOI":"10.1093\/braincomms\/fcab303","article-title":"The long and the short of Huntington's disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases","volume":"4","author":"Phillips","year":"2022","journal-title":"Brain Commun"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0670","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.plipres.2023.101224_bb0675","doi-asserted-by":"crossref","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2023.101224_bb0680","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of Huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front Neurosci"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0685","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.bbagen.2015.04.006","article-title":"A comprehensive glycome profiling of Huntington\u2019s disease transgenic mice","volume":"1850","author":"Gizaw","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0690","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00238752","article-title":"Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington\u2019s disease","volume":"44","author":"Higatsberger","year":"1981","journal-title":"Exp Brain Res"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0695","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/jnc.15325","article-title":"An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington's disease caudate nucleus","volume":"157","author":"Hunter","year":"2021","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0700","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jnc.14468","article-title":"Subventricular zone lipidomic architecture loss in Huntington's disease","volume":"146","author":"Hunter","year":"2018","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0705","doi-asserted-by":"crossref","first-page":"19354","DOI":"10.1038\/s41598-020-76335-4","article-title":"Ceramide analog [(18)F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer's disease transgenic mice by functioning as a metabolic probe","volume":"10","author":"Crivelli","year":"2020","journal-title":"Sci Rep"},{"issue":"29","key":"10.1016\/j.plipres.2023.101224_bb0710","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1039\/C5OB00951K","article-title":"A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression","volume":"13","author":"Yue","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.plipres.2023.101224_bb0715","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2019.00100","article-title":"Stimulation of sphingosine Kinase 1 (SPHK1) is beneficial in a Huntington's disease pre-clinical model","volume":"12","author":"Di Pardo","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"14","key":"10.1016\/j.plipres.2023.101224_bb0720","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","article-title":"Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease","volume":"27","author":"Di Pardo","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0725","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.plipres.2023.101224_bb0730","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","article-title":"The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives","volume":"185","author":"Huwiler","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0735","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.plipres.2023.101224_bb0740","doi-asserted-by":"crossref","first-page":"15213","DOI":"10.1038\/srep15213","article-title":"Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy","volume":"5","author":"Manchon","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0745","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/ddx046","article-title":"Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease","volume":"26","author":"Moruno-Manchon","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1433","key":"10.1016\/j.plipres.2023.101224_bb0750","first-page":"879","article-title":"Glycosphingolipid functions: insights from engineered mouse models","volume":"358","author":"Proia","year":"2003","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0755","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","article-title":"A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice","volume":"166","author":"Chiavegatto","year":"2000","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0760","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hipo.22230","article-title":"Deficits in cognitive function and hippocampal plasticity in GM2\/GD2 synthase knockout mice","volume":"24","author":"Sha","year":"2014","journal-title":"Hippocampus"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0770","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.15252\/emmm.201707763","article-title":"Disease-modifying effects of ganglioside GM1 in Huntington's disease models","volume":"9","author":"Alpaugh","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb0775","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","article-title":"Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice","volume":"109","author":"Di Pardo","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0780","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0785","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nchembio.582","article-title":"Kinase inhibitors modulate huntingtin cell localization and toxicity","volume":"7","author":"Atwal","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0790","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"J Cell Biol"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0795","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tibs.2015.04.005","article-title":"The multi-tasked life of GM1 ganglioside, a true factotum of nature","volume":"40","author":"Ledeen","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0800","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1476-5381.2009.00563.x","article-title":"Gangliosides induce autophagic cell death in astrocytes","volume":"159","author":"Hwang","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"19\u201320","key":"10.1016\/j.plipres.2023.101224_bb0805","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","article-title":"Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins","volume":"62","author":"Mocchetti","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0810","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1212\/WNL.45.6.1149","article-title":"GM1 ganglioside treatment of Parkinson\u2019s disease: an open pilot study of safety and efficacy","volume":"45","author":"Schneider","year":"1995","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0815","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.50.6.1630","article-title":"Parkinson\u2019s disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study","volume":"50","author":"Schneider","year":"1998","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.plipres.2023.101224_bb0820","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.02.009","article-title":"GM1 ganglioside in Parkinson's disease: Results of a five year open study","volume":"292","author":"Schneider","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.plipres.2023.101224_bb0825","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","article-title":"A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients","volume":"324","author":"Schneider","year":"2013","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0830","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000063604","article-title":"Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme","volume":"14","author":"Svennerholm","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082858","article-title":"GM1 oligosaccharide crosses the human blood-brain barrier in vitro by a paracellular route","volume":"21","author":"Di Biase","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10.1016\/j.plipres.2023.101224_bb0840","doi-asserted-by":"crossref","first-page":"29496","DOI":"10.1074\/jbc.M302964200","article-title":"Inhibition of calcium uptake via the sarco\/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin","volume":"278","author":"Pelled","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0845","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1471-4159.2007.04983.x","article-title":"An exposed carboxyl group on sialic acid is essential for gangliosides to inhibit calcium uptake via the sarco\/endoplasmic reticulum Ca2+-ATPase: relevance to gangliosidoses","volume":"104","author":"Ginzburg","year":"2008","journal-title":"J Neurochem"},{"issue":"31","key":"10.1016\/j.plipres.2023.101224_bb0850","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0855","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:GLYC.0000046272.38480.ef","article-title":"Glycosphingolipidoses: beyond the enzymatic defect","volume":"21","author":"Raas-Rothschild","year":"2004","journal-title":"Glycoconj J"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb0860","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.plipres.2023.101224_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102289","article-title":"Boosting mitochondrial health to counteract neurodegeneration","volume":"215","author":"Burtscher","year":"2022","journal-title":"Prog Neurobiol"},{"issue":"6921","key":"10.1016\/j.plipres.2023.101224_bb0870","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"S\u00e1nchez","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0875","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"issue":"7010","key":"10.1016\/j.plipres.2023.101224_bb0880","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.plipres.2023.101224_bb0885","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington\u2019s disease molecular pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0890","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0895","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41467-021-21637-y","article-title":"Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease","volume":"12","author":"Eshraghi","year":"2021","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.plipres.2023.101224_bb0900","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.1074\/jbc.M112.446237","article-title":"The interaction of polyglutamine peptides with lipid membranes is regulated by flanking sequences associated with huntingtin","volume":"288","author":"Burke","year":"2013","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.plipres.2023.101224_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136725","article-title":"Membrane interactions accelerate the self-aggregation of Huntingtin exon 1 fragments in a polyglutamine length-dependent manner","volume":"22","author":"Marquette","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0910","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/hmg\/ddu574","article-title":"Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington\u2019s disease","volume":"24","author":"Liu","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0915","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.bbamem.2013.04.025","article-title":"Huntingtin disrupts lipid bilayers in a polyQ-length dependent manner","volume":"1828","author":"Burke","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2023.101224_bb0920","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fneur.2013.00017","article-title":"Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration","volume":"4","author":"Burke","year":"2013","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0925","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/s41467-021-26684-z","article-title":"Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties","volume":"12","author":"Riguet","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0930","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2017.08.009","article-title":"In situ architecture and cellular interactions of PolyQ inclusions","volume":"171","author":"B\u00e4uerlein","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0935","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbrc.2016.04.034","article-title":"Expanded polyglutamine embedded in the endoplasmic reticulum causes membrane distortion and coincides with Bax insertion","volume":"474","author":"Ueda","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"10.1016\/j.plipres.2023.101224_bb0940","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183497","article-title":"Lipid headgroups alter huntingtin aggregation on membranes","volume":"1863","author":"Beasley","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb0950","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JHD-170264","article-title":"Towards an understanding of energy impairment in Huntington's Disease brain","volume":"6","author":"Dubinsky","year":"2017","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0955","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020582","article-title":"A rationale for hypoxic and chemical conditioning in Huntington's disease","volume":"22","author":"Burtscher","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb0960","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","article-title":"Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington\u2019s disease","volume":"316","author":"Mazziotta","year":"1987","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb0965","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington\u2019s disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb0970","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb0975","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.0000000000001214","article-title":"Triheptanoin improves brain energy metabolism in patients with Huntington disease","volume":"84","author":"Adanyeguh","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2023.101224_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.576592","article-title":"Mitochondrial and redox modifications in Huntington Disease induced pluripotent stem cells rescued by CRISPR\/Cas9 CAGs targeting","volume":"8","author":"Lopes","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0985","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington\u2019s disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb0990","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington\u2019s disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb0995","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tcb.2019.12.003","article-title":"How the mitoprotein-induced stress response safeguards the cytosol: a unified view","volume":"30","author":"Boos","year":"2020","journal-title":"Trends Cell Biol"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1000","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160384","article-title":"Novel metabolic abnormalities in the tricarboxylic acid cycle in peripheral cells from Huntington\u2019s disease patients","volume":"11","author":"Naseri","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/NEN.0000000000000197","article-title":"Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model","volume":"74","author":"Naseri","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1025","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000275","article-title":"Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset","volume":"4","author":"Gardiner","year":"2018","journal-title":"Neurol Genet"},{"issue":"1\u20132","key":"10.1016\/j.plipres.2023.101224_bb1030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11010-015-2561-5","article-title":"Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington\u2019s disease","volume":"410","author":"Mehrotra","year":"2015","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","article-title":"Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice","volume":"121","author":"Lee","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.plipres.2023.101224_bb1040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014352","article-title":"Mitochondrial machineries for protein import and assembly","volume":"86","author":"Wiedemann","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tibs.2017.05.002","article-title":"Cytosolic proteostasis networks of the mitochondrial stress Response","volume":"42","author":"D\u2019Amico","year":"2017","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1050","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat Neurosci"},{"issue":"33","key":"10.1016\/j.plipres.2023.101224_bb1055","doi-asserted-by":"crossref","first-page":"16593","DOI":"10.1073\/pnas.1904101116","article-title":"Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23","volume":"116","author":"Yablonska","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.plipres.2023.101224_bb1060","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1021\/pr500649m","article-title":"Proteomics of Huntington\u2019s disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances","volume":"13","author":"McQuade","year":"2014","journal-title":"J Proteome Res"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb1065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2021.183663","article-title":"Mitochondrial membranes modify mutant huntingtin aggregation","volume":"1863","author":"Adegbuyiro","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb1075","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb1080","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.molcel.2016.02.022","article-title":"Mitofusins, from Mitochondria to Metabolism","volume":"61","author":"Schrepfer","year":"2016","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12035-019-01734-2","article-title":"Energy metabolism and mitochondrial superoxide anion production in pre-symptomatic striatal neurons derived from human-induced pluripotent stem cells expressing mutant Huntingtin","volume":"57","author":"Hamilton","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"15","key":"10.1016\/j.plipres.2023.101224_bb1110","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.3390\/ijms21155412","article-title":"Mitochondrial respiration changes in R6\/2 Huntington\u2019s Disease Model mice during aging in a brain region specific manner","volume":"21","author":"Burtscher","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/exnr.2000.7626","article-title":"Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production","volume":"169","author":"Guidetti","year":"2001","journal-title":"Exp Neurol"},{"issue":"13","key":"10.1016\/j.plipres.2023.101224_bb1120","first-page":"2813","article-title":"Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress","volume":"25","author":"Lou","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1125","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/bcp.14656","article-title":"Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study","volume":"87","author":"van Diemen","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1130","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","article-title":"Mutant Huntingtin and elusive defects in oxidative metabolism and mitochondrial calcium handling","volume":"53","author":"Brustovetsky","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington\u2019s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb1140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.bbadis.2018.04.012","article-title":"Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest","volume":"1864","author":"Graham","year":"2018","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.cell.2020.03.029","article-title":"Genetic screen for cell fitness in high or low oxygen highlights mitochondrial and lipid metabolism","volume":"181","author":"Jain","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb1150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.tcb.2020.04.005","article-title":"Turning the oxygen dial: balancing the highs and lows","volume":"30","author":"Baik","year":"2020","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41467-020-20605-2","article-title":"Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington's disease mice","volume":"12","author":"Alcal\u00e1-Vida","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41467-022-27982-w","article-title":"Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens","volume":"13","author":"Rozales","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1170","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.celrep.2019.02.003","article-title":"Cell-type-specific gene expression profiling in adult mouse brain reveals normal and disease-state signatures","volume":"26","author":"Merienne","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"32","key":"10.1016\/j.plipres.2023.101224_bb1180","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1185","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/ddu561","article-title":"Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains","volume":"24","author":"Bai","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.plipres.2023.101224_bb1190","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/hmg\/ddv099","article-title":"Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington\u2019s disease mice","volume":"24","author":"Achour","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"25","key":"10.1016\/j.plipres.2023.101224_bb1195","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"Valor","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.plipres.2023.101224_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120009","article-title":"Allosteric activation of Hsp70 reduces mutant huntingtin levels, the clustering of N-terminal fragments, and their nuclear accumulation","volume":"285","author":"Pinho","year":"2021","journal-title":"Life Sci"},{"issue":"21","key":"10.1016\/j.plipres.2023.101224_bb1205","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb1210","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington's Disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"49","key":"10.1016\/j.plipres.2023.101224_bb1215","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1021\/acs.biochem.0c00788","article-title":"Phosphomimetic mutations impact huntingtin aggregation in the presence of a variety of lipid systems","volume":"59","author":"Groover","year":"2020","journal-title":"Biochemistry"},{"issue":"39","key":"10.1016\/j.plipres.2023.101224_bb1220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204396119","article-title":"Sphingosine kinases regulate ER contacts with late endocytic organelles and cholesterol trafficking","volume":"119","author":"Palladino","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acs.biochem.5b00900","article-title":"Cholesterol modifies Huntingtin binding to, disruption of, and aggregation on lipid membranes","volume":"55","author":"Gao","year":"2016","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2003.08.026","article-title":"Quantitation and molecular species determination of diacylglycerols, phosphatidylcholines, ceramides, and sphingomyelins with gas chromatography","volume":"323","author":"Tserng","year":"2003","journal-title":"Anal Biochem"},{"key":"10.1016\/j.plipres.2023.101224_bb1240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ceb.2020.01.006","article-title":"Reign in the membrane: how common lipids govern mitochondrial function","volume":"63","author":"Funai","year":"2020","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-5793(00)02332-2","article-title":"Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria","volume":"488","author":"Ardail","year":"2001","journal-title":"FEBS Lett"},{"issue":"35","key":"10.1016\/j.plipres.2023.101224_bb1250","doi-asserted-by":"crossref","first-page":"25940","DOI":"10.1074\/jbc.M701812200","article-title":"JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction","volume":"282","author":"Yu","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1255","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1074\/jbc.M110.164392","article-title":"Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis","volume":"286","author":"Novgorodov","year":"2011","journal-title":"J Biol Chem"},{"issue":"30","key":"10.1016\/j.plipres.2023.101224_bb1260","doi-asserted-by":"crossref","first-page":"20349","DOI":"10.1074\/jbc.M109.004580","article-title":"A novel mitochondrial sphingomyelinase in zebrafish cells","volume":"284","author":"Yabu","year":"2009","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.plipres.2023.101224_bb1265","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1074\/jbc.M110.102988","article-title":"Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1270","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbagen.2014.11.019","article-title":"Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization","volume":"1850","author":"Rajagopalan","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"28","key":"10.1016\/j.plipres.2023.101224_bb1275","doi-asserted-by":"crossref","first-page":"25352","DOI":"10.1074\/jbc.M110.214866","article-title":"Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA","volume":"286","author":"Novgorodov","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1285","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"},{"issue":"Pt 3","key":"10.1016\/j.plipres.2023.101224_bb1290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BJ20041627","article-title":"A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria","volume":"386","author":"Birbes","year":"2005","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington's disease","volume":"47","author":"Pratley","year":"2000","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1300","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington\u2019s disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"issue":"13\u201315","key":"10.1016\/j.plipres.2023.101224_bb1305","first-page":"887","article-title":"Adaptive responses to hypoxia and\/or hyperoxia in humans","volume":"37","author":"Burtscher","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.plipres.2023.101224_bb1310","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.730935","article-title":"Physiological responses to hypoxia on triglyceride levels","volume":"12","author":"Morin","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.plipres.2023.101224_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102228","article-title":"12\/15-Lipoxygenase debilitates mitochondrial health in intermittent hypobaric hypoxia induced neuronal damage: an in vivo study","volume":"49","author":"Choudhary","year":"2022","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0006-2952(96)00834-9","article-title":"Stress-induced apoptosis and the sphingomyelin pathway","volume":"53","author":"Pe\u00f1a","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1325","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcb.240580208","article-title":"Ceramide: a stress signal and mediator of growth suppression and apoptosis","volume":"58","author":"Obeid","year":"1995","journal-title":"J Cell Biochem"},{"issue":"5294","key":"10.1016\/j.plipres.2023.101224_bb1330","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1126\/science.274.5294.1855","article-title":"Functions of ceramide in coordinating cellular responses to stress","volume":"274","author":"Hannun","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1335","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","article-title":"Ceramide-enriched membrane domains--structure and function","volume":"1788","author":"Zhang","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1340","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbamcr.2019.01.016","article-title":"Intracellular second messengers mediate stress inducible hormesis and programmed cell death: a review","volume":"1866","author":"Zhou","year":"2019","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"issue":"6569","key":"10.1016\/j.plipres.2023.101224_bb1345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/380075a0","article-title":"Requirement for ceramide-initiated SAPK\/JNK signalling in stress-induced apoptosis","volume":"380","author":"Verheij","year":"1996","journal-title":"Nature"},{"issue":"6476","key":"10.1016\/j.plipres.2023.101224_bb1350","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/369156a0","article-title":"The stress-activated protein kinase subfamily of c-Jun kinases","volume":"369","author":"Kyriakis","year":"1994","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1355","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.268","article-title":"P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest","volume":"6","author":"Shamseddine","year":"2015","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.plipres.2023.101224_bb1360","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1194\/jlr.M067447","article-title":"ATRA transcriptionally induces nSMase2 through CBP\/p300-mediated histone acetylation","volume":"57","author":"Clarke","year":"2016","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1365","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1074\/jbc.M111.315481","article-title":"Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines","volume":"287","author":"Filosto","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2023.101224_bb1370","doi-asserted-by":"crossref","first-page":"44573","DOI":"10.1038\/srep44573","article-title":"Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.plipres.2023.101224_bb1375","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1074\/jbc.M110.163378","article-title":"Regulation of CC ligand 5\/RANTES by acid sphingomyelinase and acid ceramidase","volume":"286","author":"Jenkins","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2023.101224_bb1380","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/978-1-4419-6741-1_6","article-title":"Ceramide in stress response","volume":"688","author":"Nikolova-Karakashian","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.plipres.2023.101224_bb1385","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.bbamem.2006.08.004","article-title":"Intracellular trafficking of sphingolipids: relationship to biosynthesis","volume":"1758","author":"Futerman","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2023.101224_bb1390","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.864618","article-title":"Involvement of ceramide metabolism in cerebral ischemia","volume":"9","author":"Ouro","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.plipres.2023.101224_bb1395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2019.11.005","article-title":"Mitochondria as a therapeutic target for ischemic stroke","volume":"146","author":"He","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1400","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FJC.0b013e31819b52d5","article-title":"Ceramide and mitochondria in ischemia\/reperfusion","volume":"53","author":"Novgorodov","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/S0100-879X2011000600009","article-title":"GM1 improves neurofascin155 association with lipid rafts and prevents rat brain myelin injury after hypoxia-ischemia","volume":"44","author":"Zhang","year":"2011","journal-title":"Braz J Med Biol Res"},{"issue":"2-3","key":"10.1016\/j.plipres.2023.101224_bb1410","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.plipres.2023.101224_bb1415","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb1420","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.2337\/db15-0244","article-title":"Ceramide-initiated protein phosphatase 2A activation contributes to arterial dysfunction in vivo","volume":"64","author":"Bharath","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1425","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbrc.2008.01.132","article-title":"Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells","volume":"368","author":"Schwalm","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"3\u20134","key":"10.1016\/j.plipres.2023.101224_bb1430","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.prostaglandins.2006.03.001","article-title":"The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells","volume":"79","author":"Ahmad","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"11","key":"10.1016\/j.plipres.2023.101224_bb1435","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.yexcr.2009.03.019","article-title":"HIF-1 in the inflammatory microenvironment","volume":"315","author":"Dehne","year":"2009","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1440","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1158\/0008-5472.CAN-09-0389","article-title":"When the sphingosine kinase 1\/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy","volume":"69","author":"Ader","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1445","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/ATVBAHA.109.185280","article-title":"Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells","volume":"29","author":"Michaud","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1450","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5483\/BMBRep.2009.42.10.685","article-title":"Sphingosine 1-phosphate induces vesicular endothelial growth factor expression in endothelial cells","volume":"42","author":"Heo","year":"2009","journal-title":"BMB Rep"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1455","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1074\/jbc.M708241200","article-title":"Sphingosine Kinase 1 is up-regulated during hypoxia in U87MG glioma cells role of hypoxia-inducible factors 1 and 2","volume":"283","author":"Anelli","year":"2008","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.plipres.2023.101224_bb1460","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1158\/0008-5472.CAN-08-0917","article-title":"Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells","volume":"68","author":"Ader","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1465","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1006\/jmcc.2001.1429","article-title":"The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes","volume":"33","author":"Karliner","year":"2001","journal-title":"J Mol Cell Cardiol"},{"issue":"14","key":"10.1016\/j.plipres.2023.101224_bb1470","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine heart","volume":"110","author":"Jin","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1475","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.RES.0000253900.66640.34","article-title":"Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis","volume":"100","author":"Pchejetski","year":"2007","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1480","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cardiores.2007.01.015","article-title":"Deletion of the Sphingosine Kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes","volume":"74","author":"Tao","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1485","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1541-7786.MCR-08-0156","article-title":"Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells","volume":"7","author":"Schnitzer","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1490","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/jnc.12047","article-title":"Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL 2 signaling pathway","volume":"123","author":"Wacker","year":"2012","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.plipres.2023.101224_bb1495","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1161\/STROKEAHA.109.560714","article-title":"Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2","volume":"40","author":"Wacker","year":"2009","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.plipres.2023.101224_bb1500","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1093\/emboj\/cdg540","article-title":"Activation of sphingosine kinase 1 by ERK1\/2-mediated phosphorylation","volume":"22","author":"Pitson","year":"2003","journal-title":"EMBO J"},{"issue":"16","key":"10.1016\/j.plipres.2023.101224_bb1505","doi-asserted-by":"crossref","first-page":"12058","DOI":"10.1074\/jbc.M609559200","article-title":"Sphingosine kinase type 2 activation by ERK-mediated phosphorylation","volume":"282","author":"Hait","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1510","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-140106","article-title":"Kinase signalling in Huntington's disease","volume":"3","author":"Bowles","year":"2014","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1515","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001814RR","article-title":"Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation","volume":"35","author":"Truman","year":"2021","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1520","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tibs.2010.08.001","article-title":"Regulation of sphingosine kinase and sphingolipid signaling","volume":"36","author":"Pitson","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1525","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.cdd.4402261","article-title":"Mutant huntingtin can paradoxically protect neurons from death","volume":"15","author":"Zuchner","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.plipres.2023.101224_bb1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104371","article-title":"Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies","volume":"150","author":"Calabrese","year":"2019","journal-title":"Pharmacol Res"},{"issue":"15","key":"10.1016\/j.plipres.2023.101224_bb1535","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.plipres.2023.101224_bb1540","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1545","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(02)01111-4","article-title":"Huntington's disease transgenic mice are resistant to global cerebral ischemia","volume":"334","author":"Schiefer","year":"2002","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1550","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JHD-160189","article-title":"Delayed onset and reduced cognitive deficits through pre-conditioning with 3-nitropropionic acid is dependent on sex and CAG repeat length in the R6\/2 mouse model of Huntington's Disease","volume":"5","author":"Skillings","year":"2016","journal-title":"J Huntington's Dis"},{"issue":"8","key":"10.1016\/j.plipres.2023.101224_bb1555","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1007\/s12035-021-02397-8","article-title":"Withaferin A induces heat shock response and ameliorates disease progression in a mouse model of Huntington's disease","volume":"58","author":"Joshi","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.plipres.2023.101224_bb1560","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","article-title":"Mitochondrial-dependent apoptosis in Huntington\u2019s disease human cybrids","volume":"222","author":"Ferreira","year":"2010","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1565","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.13165","article-title":"Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington\u2019s disease","volume":"134","author":"Pellman","year":"2015","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1570","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington\u2019s Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.plipres.2023.101224_bb1575","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41380-020-00988-w","article-title":"Hippocampal neurons respond to brain activity with functional hypoxia","volume":"26","author":"Butt","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.plipres.2023.101224_bb1580","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resp.2009.10.007","article-title":"Exercise-induced VEGF transcriptional activation in brain, lung and skeletal muscle","volume":"170","author":"Tang","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.plipres.2023.101224_bb1585","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s13311-021-01089-4","article-title":"Betulinic acid hydroxamate is neuroprotective and induces protein phosphatase 2A-dependent HIF-1\u03b1 stabilization and post-transcriptional dephosphorylation of prolyl hydrolase 2","volume":"18","author":"Prados","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.plipres.2023.101224_bb1590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194580","article-title":"XJB-5-131-mediated improvement in physiology and behaviour of the R6\/2 mouse model of Huntington's disease is age- and sex- dependent","volume":"13","author":"Polyzos","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2023.101224_bb1595","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2020.10.022","article-title":"NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model","volume":"162","author":"Moretti","year":"2021","journal-title":"Free Radic Biol Med"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782723000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782723000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:48:05Z","timestamp":1759013285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782723000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":311,"alternative-id":["S0163782723000140"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2023.101224","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipids and impaired hypoxic stress responses in Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2023.101224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101224"}}